Food and beverage makers are adjusting as more people take GLP-1s and eat differently. A look at what is shifting across the business.
Recap by typeshit. Post by Facebook on Facebook.
The surgeon says that after a 45 lb loss on a GLP-1, getting enough daily protein with a low appetite becomes the harder part.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
The writer cites a Gallup survey putting about 11 percent of Americans on GLP-1s and argues the real share is likely higher, and wants use discussed openly.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
Drugs may be considered for ages 10 to 19 only after supervised programs fail. WHO says GLP-1 evidence in children is still too thin.
Drugs.com
An evergreen explainer on diagnosis and treatment options, noting Wegovy and Zepbound can bring about 15% to 21% weight loss with lifestyle changes.
Loading…